You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NAD-booster

Showing 1 - 25 of 1,080
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, NAD Trial in San Antonio (Nicotinamide riboside, Sugar Pill)

Completed
  • Mild Cognitive Impairment
  • NAD
  • Nicotinamide riboside
  • Sugar Pill
  • San Antonio, Texas
  • +1 more
Aug 31, 2021

Meningococcal B Disease Trial in Worldwide (rLP2086 vaccine, Pediatric HAV vaccine)

Completed
Has Results
  • Meningococcal B Disease
  • rLP2086 vaccine
  • Pediatric HAV vaccine
  • Canberra, Garran, Australian Capital Territory, Australia
  • +24 more
Aug 30, 2021

Mitochondrial Health and Hemodynamic Instability Related to

Recruiting
  • Acute Kidney Injury (AKI)
    • Ottawa, Ont, Canada
      The Ottawa Hospital
    Feb 28, 2022

    Yellow Fever Trial (17D Yellow fever vaccine)

    Not yet recruiting
    • Yellow Fever
    • 17D Yellow fever vaccine
    • (no location specified)
    Apr 11, 2022

    Mitochondrial Myopathies Trial in Helsinki (Niacin)

    Completed
    • Mitochondrial Myopathies
    • Niacin
    • Helsinki, Finland
      University of Helsinki
    Jan 21, 2021

    Enhance Immune Function Trial (NMN)

    Not yet recruiting
    • Enhance Immune Function
    • (no location specified)
    Aug 2, 2023

    Meningococcal Infections Trial in Worldwide (MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate

    Active, not recruiting
    • Meningococcal Infections
    • MenACYW conjugate vaccine
    • +5 more
    • Chlumec Nad Cidlinou, Czechia
    • +30 more
    Jan 4, 2023

    NAD+/NADH in Peripheral Blood Samples of Different Gender and

    Not yet recruiting
    • NAD+/NADH in Peripheral Blood Monitoring
    • Detection of NAD+/NADH concentration of Peripheral Blood Samples
    • Shanghai, Shanghai, China
      Shanghai Mengchao Cancer Hospital
    Aug 11, 2023

    Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)

    Recruiting
    • Healthy
    • nicotinamide riboside
    • nicotinamide mononucleotide
    • Bergen, Vestland, Norway
      Haukeland University Hospital
    Jan 25, 2023

    Covid19, Long COVID-19, Post-COVID-19 Syndrome Trial in Ann Arbor (Naltrexone, NAD+)

    Completed
    • Covid19
    • +2 more
    • Ann Arbor, Michigan
      AgelessRx
    Jan 23, 2023

    COVID-19 Trial in United States (Vaccine Messaging, Vaccine Acceptance Question)

    Not yet recruiting
    • COVID-19
    • Vaccine Messaging
    • Vaccine Acceptance Question
    • San Francisco, California
    • +6 more
    Dec 1, 2023

    Skeletal Muscle Trial in Orlando (Deuterated nicotinamide (D4-NAM) IV infusion, Skeletal muscle biopsy, Skin tissue biopsy)

    Recruiting
    • Skeletal Muscle
    • Deuterated nicotinamide (D4-NAM) IV infusion
    • +2 more
    • Orlando, Florida
      AdventHealth Translational Research Institute
    Aug 2, 2022

    Coronary Artery Disease Trial (SIT LESS Booster)

    Not yet recruiting
    • Coronary Artery Disease
    • SIT LESS Booster
    • (no location specified)
    Sep 7, 2023

    Method Optimization for the Quantification of the NAD

    Completed
    • NAD
    • Laboratory method validation
    • Lausanne, Switzerland
      Clinical Innovation Lab.
    Sep 27, 2022

    Neck Pain, Whiplash, Pain, Acute Trial in Winterthur (no intervention)

    Not yet recruiting
    • Neck Pain
    • +8 more
    • no intervention
    • Winterthur, Zurich, Switzerland
      Zurich University of Applied Sciences: School of Health Sciences
    Jul 18, 2022

    RELIABILITY AND VALIDITY OF THE DT BALANCE TEST IN PATIENTS WITH

    Active, not recruiting
    • Knee Injuries and Disorders
    • Osteo Arthritis Knee
      • İzmir, Turkey
        Dokuz Eylul University
      Oct 25, 2023

      Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)

      Not yet recruiting
      • Type2diabetes
      • Diabetic Kidney Disease
      • Investigational Product - MIB 626
      • Placebo
      • (no location specified)
      Mar 6, 2023

      COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)

      Active, not recruiting
      • COVID-19
      • NVX-CoV2373
      • SARS-CoV-2 rS antigen/Matrix-M Adjuvant
      • Austin, Texas
      • +4 more
      May 16, 2023

      Circadian Rhythm on Brain NAD Measured by Phosphorus Magnetic

      Recruiting
      • Circadian Rhythm
        • Lausanne, Vaud, Switzerland
          Center for Biomedical Imaging, École polytechnique fédérale de L
        Oct 25, 2021

        Ketoses, Metabolic, Ketogenic Dieting, Alcohol Intoxication Trial in Philadelphia (dietary supplement, other, drug)

        Not yet recruiting
        • Ketoses, Metabolic
        • +4 more
        • Ketone Supplement
        • +3 more
        • Philadelphia, Pennsylvania
          University of Pennsylvania Center for Studies of Addiction
        Sep 29, 2023

        SARS-CoV-2 Infection, Acute Kidney Injury Trial in New York, San Antonio, Seattle (Placebo, Nicotinamide riboside)

        Active, not recruiting
        • SARS-CoV-2 Infection
        • Acute Kidney Injury
        • Placebo
        • Nicotinamide riboside
        • New York, New York
        • +3 more
        Oct 25, 2022

        Friedreich Ataxia 1 Trial in Philadelphia (Nicotinamide Riboside, Placebo, Exercise Intervention)

        Recruiting
        • Friedreich Ataxia 1
        • Nicotinamide Riboside
        • +2 more
        • Philadelphia, Pennsylvania
          Children's Hospital of Philadelphia
        Sep 21, 2022

        NAD Trial in Berlin (Niagen, Placebo)

        Not yet recruiting
        • NAD
        • Niagen
        • Placebo
        • Berlin, Germany
          Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
        Aug 22, 2023

        COVID-19, Vaccines Trial in Los Angeles (Reminder that facilitates action, Consistency framing, Information provision about the

        Recruiting
        • COVID-19
        • Vaccines
        • Reminder that facilitates action
        • +4 more
        • Los Angeles, California
          UCLA Health Department of Medicine, Quality Office
        Nov 8, 2022

        Friedreich Ataxia Trial in Philadelphia (MIB-626)

        Active, not recruiting
        • Friedreich Ataxia
        • Philadelphia, Pennsylvania
          The Children's Hospital of Philadelphia
        Oct 26, 2022